Going up to 7.5mg Mounjaro: what the decision actually involves

The biggest misconception: that moving up means the previous dose isn't working

A lot of people assume that if they're still on 5mg after eight weeks, something has gone wrong. It hasn't. The titration schedule for Mounjaro exists primarily to protect tolerability, not to describe a race. The 2.5mg starter dose is there so your gut adjusts gradually, nausea and vomiting are common early on and tend to ease within the first couple of weeks at any new dose. Moving to 5mg, then to 7.5mg, continues that protective logic.

What sometimes gets lost is that 5mg is a genuinely therapeutic dose, not a waiting room. Clinical trial data show meaningful weight loss across all doses in the Mounjaro programme, and some people find 5mg is the level where they lose weight steadily with good tolerability. The question isn't whether 7.5mg is stronger (it is) but whether a stronger dose is what you need at this point. Gently letting go of the idea that dose progression equals success changes how you approach this conversation with your prescriber.

You can read more about what the 5mg phase involves on our Mounjaro 5mg guide, which covers what to expect during that part of treatment.

What your prescriber looks at before recommending 7.5mg

A prescriber reviewing whether to increase your dose to 7.5mg is weighing several things at once. First, how you tolerated 5mg: significant ongoing nausea, vomiting or difficulty eating at 5mg would generally argue against going higher straight away. Second, your weight-loss trajectory: if you're losing weight at a pace that's clinically appropriate and comfortable, there's no compelling reason to escalate. Third, the time you've spent at 5mg: the licensed titration schedule recommends at least four weeks at each dose, and most clinical pathways treat that as a minimum rather than a target.

There's also a practical consideration around evidence. At nume, dose increases require clinical review before each repeat, a real prescriber, not software, looks at what's happened since your last supply was dispensed. That review is the appropriate moment to raise whether 7.5mg makes sense. Our guide on moving up a dose on Mounjaro walks through the general principles in more detail if you want a broader picture before that conversation.

According to NICE's appraisal of tirzepatide, TA1026, treatment should be reviewed if less than five percent weight loss is achieved after six months at the highest tolerated dose, which implies that dose optimisation matters, but so does identifying the right dose for each person rather than always pursuing the maximum.

Side effects at 7.5mg: what commonly changes and what stays the same

Most people who experience gastrointestinal side effects on Mounjaro notice they're most prominent in the first one to two weeks after a dose increase. At 7.5mg this pattern typically repeats: nausea, loose stools, reduced appetite and occasional reflux are all reported more frequently in the period immediately after moving up. For the majority these settle, just as they did when moving from 2.5mg to 5mg.

What doesn't change is the importance of keeping up fluid intake and eating protein-adequate meals even when appetite falls sharply. A higher dose suppresses hunger more effectively, which can feel like a win but also makes it easier to under-eat in ways that cause fatigue or dizziness. The NHS medicines page for tirzepatide lists the common side effects and the signs that warrant prompt medical attention, it's worth reading before any dose change.

If you're weighing up the step after this one too, our guide to moving to 10mg covers similar ground for that transition.

How to approach the dose conversation at your next review

The most useful thing you can do before your next clinical review is keep a simple record: how has your weight changed week to week, what side effects did you notice and when, and how is your appetite and energy now compared with when you started 5mg? That information gives a prescriber something concrete to work from rather than a general sense that things are going okay.

It's also worth being honest about tolerability. Some people underreport side effects because they don't want to seem like they're struggling, or because they're keen to move up. A prescriber recommending 7.5mg on incomplete information isn't doing you a favour, they need the full picture to make the right call. The general question of whether and when to increase your dose is something our dose-increase overview addresses, including the factors that might mean staying put is actually the better option.

If you're thinking about what treatment costs at different stages of your journey, the Mounjaro cost guide sets out what private treatment typically involves in the UK. And if you're new to Mounjaro overall, our Mounjaro overview covers the medicine from the beginning.

When you're ready to discuss your next dose with a clinical team, speak to our prescribers for a same-day review by a GPhC-registered Independent Prescriber who can look at your individual progress and help you decide together.